Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)

NCT07511569 is registered in ClinicalTrials.gov with Centre Hospitalier de Bligny as lead sponsor.

NCT NCT07511569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Lead sponsor
Centre Hospitalier de Bligny
Phase
Observational
Overall status
Not yet recruiting
Start date
January 4, 2027
Completion date
June 4, 2029
Enrollment
192 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced neuropathic pain, neuropathy toxic, oxaliplatin induced peripheral neuropathy in cancer patients, taxane-induced peripheral neuropathy